This website is intended for UK healthcare professionals only Log in | Register

Tag Archives: GLP-1 receptor agonists

March 2024 Br J Cardiol 2024;31:11

The failing heart and kidney: improving prevention and treatment

Mohammad Wasef, Sarah Birkhoelzer

Abstract

New generation diabetes drugs – a cardiorenal done deal? The meeting was opened by Professor William Herrington (Honorary Consultant Nephrologist, Oxford Kidney Unit) who discussed the impact of the new generation diabetes drugs on kidney outcomes.1 A meta-analysis of over 90,000 patients showed that sodium glucose co-transporter-2 (SGLT2) inhibitors slowed chronic kidney disease (CKD) progression by 37%, and decreased the risk of acute kidney injury, cardiovascular (CV) death or heart failure hospitalisation by 23%, regardless, the presence of diabetes or type of SGLT2 inhibitor used. Implementing these drugs is simple and can be done by

| Full text

February 2024 Br J Cardiol 2024;31:9–10

BSH 2023: collaboration, coordination and cooperation – 25in25

J. Aaron Henry

Abstract

25in25 The meeting began with an update on the 25in25 initiative from BSH Chair-Elect Dr Lisa Anderson (St George’s University Hospital, London). This national quality improvement initiative, led by the BSH in collaboration with over 54 national and international healthcare organisations, has the goal of reducing heart failure deaths by 25% over the next 25 years. With already over one million people in the UK living with heart failure, a number which is expected to double by 2040, the ambitious initiative is eagerly awaited. In the UK alone this could translate to over 10,000 lives saved per year. A population health approach underpins th

| Full text

February 2023 Br J Cardiol 2023;30:12–15

Cardiorenal medicine – new targets, treatments and technologies

Karin Pola, Sarah Birkhoelzer

Abstract

What’s new in transplantation Are kidney donors worse off? The meeting was opened by Dr Anna Price (Queen Elizabeth University Hospital, Birmingham) who addressed the long-term cardiovascular effects of unilateral nephrectomy in living kidney donors.1 Previous studies have shown a significant prevalence of cardiovascular morbidity and mortality in patients with chronic kidney disease (CKD),2,3 but the effects of reduced renal function in living kidney donors has been unexplored until now. A recent study by Price et al. demonstrated that living kidney donors had a reduction in estimated glomerular filtration rate (eGFR) from 95 to 67 ml/min

| Full text
Introduction

September 2018 Br J Cardiol 2018;25(suppl 2):S3 doi:10.5837/bjc.2018.s06

Introduction

Naveed Sattar

Abstract

The risk of developing type 2 diabetes is amplified among the South Asian population in the UK, with estimates suggesting a two- to fourfold increase in risk. Why is this? Hanif and Susarala review putative reasons why South Asian people represent at least 15% of the population of people with diabetes in this country, and who also carry higher microvascular complication rates than their European counterparts. Although the reasons for excess coronary heart disease (CHD) mortality risk in South Asians are not entirely clear, studies have found higher levels of conventional risk factors present at a younger age, which may be an explanation for

| Full text
Prescribing glucose-lowering drugs for patients with cardiac disease

June 2018 Br J Cardiol 2018;25:73–6 doi:10.5837/bjc.2018.016

Prescribing glucose-lowering drugs for patients with cardiac disease

Miles Fisher, Emma Johns, Gerry McKay

Abstract

(more…)

| Full text
Glucagon-like peptide-1 (GLP-1) receptor agonists

November 2017 Br J Cardiol 2017;24:152–5 doi:10.5837/bjc.2017.030

Glucagon-like peptide-1 (GLP-1) receptor agonists

Emma Johns, Gerry McKay, Miles Fisher

Abstract

(more…)

| Full text
Drugs for diabetes: part 6 GLP-1 receptor agonists

August 2011 Br J Cardiol 2011;18:167–69

Drugs for diabetes: part 6 GLP-1 receptor agonists

Claire McDougall, Gerard A McKay, Miles Fisher

Abstract

(more…)

| Full text

For healthcare professionals only

Add Banner

Close

You are not logged in

You need to be a member to print this page.
Find out more about our membership benefits

Register Now Already a member? Login now
Close

You are not logged in

You need to be a member to download PDF's.
Find out more about our membership benefits

Register Now Already a member? Login now